Blood Plasma Derivatives Market
According to Intent Market Research, the Blood Plasma Derivatives Market is expected to grow from USD 30.6 billion in 2023 at a CAGR of 8.5% to touch USD 54.1 billion by 2030. The Blood Plasma Derivatives Market is dominated by key players such as Grifols, CSL Behring, Takeda Pharmaceutical Company, Octapharma, Baxter International Inc., Biotest AG, Kedrion Biopharma, LFB Group, Shanghai RAAS Blood Products Co., Emergent BioSolutions Inc., China Biologic Products, Sanquin, Ferring Pharmaceuticals, Blood Plasma Technologies, Hi-Tech BioSolutions.